SA’s medicines regulator has come under attack from the financial backers of the Russian Covid-19 vaccine Sputnik V, who say its failure to grant the product emergency use authorisation threatens to torpedo their plans to set up a manufacturing site in Cape Town.

The Russian Direct Investment Fund (RDIF) financed the Gamalaya Institute’s development of Sputnik V. It was the first Covid-19 vaccine to be registered for use in any country and is being used in more than 70 nations, including Hungary, Brazil and Zimbabwe...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now